GASTROINTESTINAL HEMORRHAGE
Clinical trials for GASTROINTESTINAL HEMORRHAGE explained in plain language.
Never miss a new study
Get alerted when new GASTROINTESTINAL HEMORRHAGE trials appear
Sign up with your email to follow new studies for GASTROINTESTINAL HEMORRHAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental antibody shows promise for rare amyloid disease
Disease control CompletedThis phase II trial tested the drug isatuximab in 43 patients with AL amyloidosis that had come back or stopped responding to treatment. Isatuximab is a monoclonal antibody that may help stop abnormal protein buildup. The study measured how well the drug reduced disease markers a…
Matched conditions: GASTROINTESTINAL HEMORRHAGE
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 26, 2026 15:04 UTC
-
Chatbot boosts doctor trust in AI for bleeding emergencies?
Knowledge-focused CompletedThis study tested whether adding a chatbot interface makes doctors more likely to trust and use an AI tool that predicts risk in patients with upper stomach bleeding. 108 medical residents participated in simulated emergency scenarios, some using the AI alone and others using the…
Matched conditions: GASTROINTESTINAL HEMORRHAGE
Phase: NA • Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC